Stock Price Quote

KRISHNA INSTITUTE OF MEDICAL SCIENCES LTD

NSE : KIMSBSE : 543308ISIN CODE : INE967H01017Industry : Hospital & Healthcare ServicesHouse : Private
BSE1947.15-2.2 (-0.11 %)
PREV CLOSE ( ) 1949.35
OPEN PRICE ( ) 1938.30
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2694
TODAY'S LOW / HIGH ( )1921.55 1970.00
52 WK LOW / HIGH ( )1452.6 2357
NSE1946.10-1.8 (-0.09 %)
PREV CLOSE( ) 1947.90
OPEN PRICE ( ) 1942.60
BID PRICE (QTY) 1946.10 (1000)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 149333
TODAY'S LOW / HIGH( ) 1910.00 1972.35
52 WK LOW / HIGH ( )1457.05 2356.4
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 26-07 1973
Management Info
Bhaskara Rao Bollineni - Chairman Bhaskara Rao Bollineni - Managing Director
Registered Office

Address D. No.1-8-31/1,Minister's Road, ,
Secunderabad,
Telangana-500003

Phone 040-44186000 / 44850000 / 44885184

Email cs@kimshospitals.com

Website www.kimshospitals.com

Registrars Details
Link Intime India Pvt Ltd.
Coimbatore Branch Surya , 35 Mayflower Avenue,Behind Senthil Nagar,Sowripalayam Road,Coimbatore
Listing : BSE, NSE

NEWS

25Jan Krishna Institute of Medical Sciences
In terms of provisions of Regulation 30 read with Schedule III of the Li..
23Jan Krishna Institute of Medical Sciences
Krishna Institute of Medical Sciences has informed that the meeting of t..
10Jan Krishna Institute of Medical acquires
Krishna Institute of Medical Sciences has made a further investment by a..
08Jan Krishna Institute of Medical Sciences
In terms of provisions of Regulation 30 read with Schedule III of the Li..
01Dec Krishna Institute of Medical Sciences
Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Re..

Financials

in Millions
QTR Dec 23 ANNUAL 23
Net Profit583.552524.89
Gross Profit 777.07 3373.33
Operating Profit 917.063837.8
Net Sales 3020.6311320.23

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Apollo Hospital Ent. (BSE)
peergroup  6170.05 (1.68%)
M.Cap ( in Cr)88715.85
Global Health (BSE)
peergroup  1402.45 (2.25%)
M.Cap ( in Cr)37656.82
Dr Agarwals Eye Hsp (BSE)
peergroup  3282.00 (0.94%)
M.Cap ( in Cr)1542.54
Thyrocare Tech. (BSE)
peergroup  634.85 (2.99%)
M.Cap ( in Cr)3361.70
Yatharth Hospital (BSE)
peergroup  460.10 (2.39%)
M.Cap ( in Cr)3949.97

Shareholding Pattern

FI/BANKS/INSURANCE 5.61%
PROMOTERS 38.82%
MUTUAL FUNDS/UTI 26.33%
NON-INSTITUTION 11.32%
GOVERNMENT 0%
FII 0%

About Krishna Institute of Medical Sciences Ltd

Krishna Institute of Medical Sciences Ltd was incorporated in the year 1973. Its today's share price is 1947.15. Its current market capitalisation stands at Rs 15582.61 Cr. In the latest quarter, company has reported Gross Sales of Rs. 11320.23 Cr and Total Income of Rs.11563.06 Cr. The company's management includes Adwik Bollineni, Ratna Kishore Kaza, Y Prameela Rani, Abhinay Bollineni, Venkata Ramudu Jasthi, Saumen Chakraborty, Anitha Dandamudi, Bhaskara Rao Bollineni, Bhaskara Rao Bollineni, Umashankar Mantha.

It is listed on the BSE with a BSE Code of 543308 , NSE with an NSE Symbol of KIMS and ISIN of INE967H01017. It's Registered office is at D. No.1-8-31/1,Minister's Road, Secunderabad-500003, Telangana. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are B Naga Bhushan & Co, BSR & Associates, BSR & Associates LLP, SR Batliboi & Associates LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.